{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:14:10Z","timestamp":1793330050987,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jlr.2023.100485","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T17:55:32Z","timestamp":1702576532000},"page":"100485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":257,"title":["From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease"],"prefix":"10.1016","volume":"65","author":[{"given":"Mary E.","family":"Rinella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5929-5470","authenticated-orcid":false,"given":"Silvia","family":"Sookoian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2023.100485_bib1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100485_bib2","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/hep.32774","article-title":"Geographical similarity and differences in the burden and genetic predisposition of NAFLD","volume":"77","author":"Yip","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100485_bib3","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jlr.2023.100485_bib4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2023.100485_bib5","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1053\/j.gastro.2016.01.002","article-title":"How safe is moderate alcohol consumption in overweight and obese individuals?","volume":"150","author":"Sookoian","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2023.100485_bib6","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2023.100485_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jlr.2023.100485_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0041-1730927","article-title":"Insights into nonalcoholic fatty-liver disease heterogeneity","volume":"41","author":"Arrese","year":"2021","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jlr.2023.100485_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/17474124.2023.2191190","article-title":"Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making","volume":"17","author":"Pirola","year":"2023","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2023.100485_bib10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.31229","article-title":"Genetic pathways in nonalcoholic fatty liver disease: insights from systems biology","volume":"72","author":"Sookoian","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100485_bib11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jlr.2023.100485_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100073","article-title":"The lipidome in nonalcoholic fatty liver disease: actionable targets","volume":"62","author":"Pirola","year":"2021","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100485_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and N","volume":"15","author":"Wong","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2023.100485_bib14","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2023","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.jlr.2023.100485_bib15","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100485_bib16","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100485_bib17","first-page":"05279","article-title":"Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease","volume":"S0168-8278","author":"Younossi","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100485_bib18","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jhep.2022.11.028","article-title":"NAFLD and NASH biomarker qualification in the LITMUS consortium - lessons learned","volume":"78","author":"Rasmussen","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100485_bib19","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41591-021-01652-8","article-title":"Non-invasive biomarkers of nonalcoholic steatohepatitis: the FNIH NIMBLE project","volume":"28","author":"Sanyal","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jlr.2023.100485_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2022.08.030","article-title":"Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease","volume":"78","author":"Aberg","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100485_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-022-05398-2","article-title":"A\u00a0multinational Delphi consensus to end the COVID-19 public health threat","volume":"611","author":"Lazarus","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2023.100485_bib22","first-page":"04996","article-title":"Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD","volume":"S0168-8278","author":"Ratziu","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100485_bib23","first-page":"05000","article-title":"Can we use old NAFLD data under the new MASLD definition?","volume":"S0168-8278","author":"Song","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100485_bib24","article-title":"Prevalence, distribution and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings","author":"Lee","year":"2023","journal-title":"Hepatology"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752300158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752300158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T23:05:09Z","timestamp":1756767909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002222752300158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S002222752300158X"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2023.100485","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2023.100485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100485"}}